Finding Value in Linking Real-World Data with Social Determinants of Health
Hear Pamela Landsman-Blumberg and Rick Chapman highlight the importance of SDOH and discuss examples of how claims data and EMR linked with SDOH can inform use cases.
Economic Impact of Representativeness in Clinical Trials: How Real-World Data Can Help
This panel of real-world evidence (RWE) experts will explore the economic impact and role of RWE in improving representativeness of research.
Stay Ahead of the Game: Learn How to Conduct an Evidence-Based GVD Faster and Smarter to Improve Market Access
Hear several experts address systematic literature review issues that can negatively affect your Global Value Dossiers (GVDs) and how automation can improve your product's market access.
Health Economic and Outcome Research (HEOR) for Medical Technologies for the US Healthcare Systems
Deepak Sahu, MBA, explains how HEOR studies are important for generating useful effectiveness data for success of medical technologies.
Streamlining Health Technology Assessments by Automating Literature Reviews
Experts provide a deep dive into what Health Technology Assessment (HTA) agencies do and the types of literature reviews they do.
Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Experts present opportunities for using agile platforms and fit-for-purpose engagement models that can drive an iterative approach to obtaining payer insights and developing impactful evidence generation strategies.
Optimize Your Value Story Through Integrated Evidence Generation – From Bench to Patient
A panel of experts discuss evidence generation planning to optimize clinical and commercial success and improve patient outcomes.
Using Real-World Data to Explore and Demonstrate Comparative Effectiveness
Dr. Jessica Paulus explores opportunities and challenges with using RWD in conducting comparative effectiveness research.
Real-World Data for Mental Health – Understanding Outcomes and Unlocking Pathways to More Precise Treatments
Real-World Data for Mental Health – Understanding Outcomes and Unlocking Pathways to More Precise Treatments OM1 was [...]
Unlocking the Value of Real-World Data to Provide Real-World Care
Unlocking the Value of Real-World Data to Provide Real-World Care For this tHEORetically Speaking video interview, Mary Tran, [...]
Differentiate Your Product From the Competition: Give Payers the Insights They Need
Differentiate Your Product From the Competition: Give Payers the Insights They Need In this competitive pharmaceutical [...]
Optimizing Real-World Evidence for Maternal and Neonatal Outcomes
Experts from health system innovators (C-Path), patients (PreemieWorld), healthcare payers (HealthCore/Anthem), and industry (Bayer) provide insights into improving neonatal outcomes using RWE.
How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies
Literature reviews are an essential element in Real World Evidence (RWE) HEOR studies that impact patient care, policy development, and healthcare decision making.
Value-Based Agreements – Are We Going to See More or Less of Them?
Mike Pace, MBA, Pierre Etienne, MD, and Clifton Chow give an insightful and practical webinar on one of the most important areas in pharmaceutical value and market access.
Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?
Michael Broder, President, PHAR and Jesse Ortendhal, Director of Health Economics, PHAR present on literature review automation in clinic.
